Integrated BioPharma's total assets for Q3 2026 were $26.67M, an increase of 13.26% from the previous quarter. INBP total liabilities were $7.69M for the fiscal quarter, a 103.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.